Michael Patrick Miller, EVP, US Commercial at Jazz Pharmaceuticals plc (JAZZ), sold 1,500 shares at $149.12 ($224K) on 2019-12-09, disclosed to the SEC on 2019-12-10.
Seasonal sale ($224k) by EVP, US Commercial — this insider has traded JAZZ in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| PBYI | SELL | 2023-11-09 | $71K | — | Filing → |
| PBYI | SELL | 2023-06-15 | $47K | — | Filing → |
| PBYI | SELL | 2022-08-10 | $89K | — | Filing → |